Literature DB >> 29478102

Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.

Victoria Kapustian1, Ahmet Namazov2, Odeliya Yaakov1, Michael Volodarsky1, Eyal Y Anteby1, Ofer Gemer1.   

Abstract

PURPOSE: Tubo-ovarian abscess (TOA) is a serious and potentially life-threatening complication of pelvic inflammatory disease (PID). TOA formation may be an uncommon, but serious complication associated with the use of an intrauterine device (IUD). While the majority of TOA respond to antibiotic therapy, in approximately 25% of cases surgery or drainage is indicated. In the present study, we compared the failure rate of conservative management in patients with and without IUD, who were admitted with a diagnosis of TOA.
METHODS: In this retrospective case-control study, 78 women were diagnosed with TOA. All patients were treated initially by broad-spectrum intravenous antibiotics. The failure of conservative management after 72 h was followed by surgical intervention.
RESULTS: The patients were divided into two groups: 24 patients were IUD-carriers, and 54 did not use IUD. There was no significant difference in surgical intervention rate between IUD group (50%) and no-IUD group (43%), p = 0.32. The WBC count was significantly higher in IUD-carriers diagnosed with TOA than in patients without IUD (16.5 ± 6.6 vs. 13.1 ± 4.6, p = 0.001). The patients with IUD had significantly larger abscesses as revealed by ultrasound than patients without IUD (61.6 ± 21.4 vs. 49.6 ± 20.6 mm, p = 0.02).
CONCLUSION: The surgical intervention rate in TOA patients with and without IUD was similar.

Entities:  

Keywords:  Conservative management; Intrauterine device; Tubo-ovarian abscess

Mesh:

Substances:

Year:  2018        PMID: 29478102     DOI: 10.1007/s00404-018-4690-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Factors associated with an unfavorable clinical course in hospitalized patients with pelvic inflammatory disease: a retrospective cohort study of 117 patients from a Japanese academic institution.

Authors:  Naoko Matsuda; Seung Chik Jwa; Saki Tamura; Hiroyuki Suzuki; Masashi Takamura; Akira Namba; Takeshi Kajihara; Ryugo Okagaki; Yoshimasa Kamei; Osamu Ishihara
Journal:  BMC Womens Health       Date:  2022-08-17       Impact factor: 2.742

2.  Endometriosis is a risk factor for recurrent pelvic inflammatory disease after tubo-ovarian abscess surgery.

Authors:  Maria Zografou Themeli; Konstantinos Nirgianakis; Stephanie Neumann; Sara Imboden; M D Mueller
Journal:  Arch Gynecol Obstet       Date:  2022-08-29       Impact factor: 2.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.